$1.23
+0.07
(+6.03%)▲
5.69%
Downside
Day's Volatility :6.45%
Upside
0.81%
59.46%
Downside
52 Weeks Volatility :71.01%
Upside
28.49%
Period | Sellas Life Sciences Group Inc | Index (Russel 2000) |
---|---|---|
3 Months | 1.65% | 0.0% |
6 Months | -4.65% | 0.0% |
1 Year | 35.18% | 0.0% |
3 Years | -86.79% | -27.1% |
Market Capitalization | 74.6M |
Book Value | $0.05 |
Earnings Per Share (EPS) | -0.9 |
Wall Street Target Price | 5.83 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -129.15% |
Return On Equity TTM | -888.06% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -82.5% |
Gross Profit TTM | 900.0K |
Diluted Eps TTM | -0.9 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.57 |
EPS Estimate Next Year | -0.43 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | -0.15 |
What analysts predicted
Upside of 373.98%
Sell
Neutral
Buy
Sellas Life Sciences Group Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Sellas Life Sciences Group Inc | 3.36% | -4.65% | 35.18% | -86.79% | -78.23% |
Regeneron Pharmaceuticals, Inc. | -18.16% | -14.42% | 3.52% | 34.42% | 140.62% |
Biontech Se | -5.81% | 20.18% | 11.4% | -51.12% | 460.49% |
Alnylam Pharmaceuticals, Inc. | 2.41% | 83.28% | 68.63% | 50.84% | 200.09% |
Vertex Pharmaceuticals Incorporated | 10.42% | 23.33% | 40.2% | 170.42% | 155.94% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Sellas Life Sciences Group Inc | NA | NA | NA | -0.57 | -8.88 | -1.29 | NA | 0.05 |
Regeneron Pharmaceuticals, Inc. | 20.41 | 20.41 | 1.2 | 44.89 | 0.17 | 0.07 | NA | 272.04 |
Biontech Se | 160.8 | NA | 0.04 | -3.1 | -0.02 | -0.01 | NA | 79.73 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -1.87 | -15.01 | -0.03 | NA | 0.25 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 1.27 | 0.19 | -0.03 | 0.13 | NA | 60.66 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Sellas Life Sciences Group Inc | Buy | $74.6M | -78.23% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $90.6B | 140.62% | 20.41 | 33.61% |
Biontech Se | Buy | $25.9B | 460.49% | 160.8 | -15.36% |
Alnylam Pharmaceuticals, Inc. | Buy | $35.1B | 200.09% | NA | -15.86% |
Vertex Pharmaceuticals Incorporated | Buy | $128.9B | 155.94% | 32.84 | -4.51% |
Insights on Sellas Life Sciences Group Inc
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.6% return, outperforming this stock by 33.4%
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 50.8% return, outperforming this stock by 137.6%
Vanguard Group Inc
Geode Capital Management, LLC
BlackRock Inc
Opus Capital Group LLC
Equitable Holdings Inc
Diametric Capital, LP
σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.
Organization | Sellas Life Sciences Group Inc |
Employees | 16 |
CEO | Dr. Angelos M. Stergiou M.D., ScD h.c. |
Industry | Health Technology |
Cactus Acquisition Corp 1 Ltd
$1.23
+6.03%
Rigel Resource Acquisition Corp
$1.23
+6.03%
Fortune Rise Acquisition Corp
$1.23
+6.03%
Canada Goose Holdings Inc.
$1.23
+6.03%
J W Mays Inc
$1.23
+6.03%
American Shared Hospital Services
$1.23
+6.03%
Cambria Shareholder Yield Etf
$1.23
+6.03%
J-long Group Ltd.
$1.23
+6.03%
Cps Technologies Corp
$1.23
+6.03%